Heterozygous Bβ-chain C-terminal 12 amino acid elongation variant, BβX462W (Kyoto VI), showed dysfibrinogenemia

Blood Coagulation and Fibrinolysis

Volumn 23, Issue 1, 2012, Pages 87-90

  Okumura, Nobuo ^a   Terasawa, Fumiko ^a   Takezawa, Yuka ^a,b   Hirota Kawadobora, Masako ^b   Inaba, Tohru ^c   Fujita, Naohisa ^c   Saito, Masazumi ^d   Sugano, Mitsutoshi ^b   Honda, Takayuki ^e  

^a SHINSHU UNIVERSITY   (Japan)

^b SHINSHU UNIVERSITY HOSPITAL   (Japan)

^c Laboratory Medicine   (Japan)

^d KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^e SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

albumin binding form; B chain; dysfibrinogen; variant dimeric fibrinogen

Indexed keywords

FIBRIN; FIBRINOGEN VARIANT; KYOTO VI FIBRINOGEN; UNCLASSIFIED DRUG;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BETA CHAIN; BLEEDING; CARBOXY TERMINAL SEQUENCE; CASE REPORT; CONTROLLED STUDY; DISULFIDE BOND; DNA SEQUENCE; DYSFIBRINOGENEMIA; FEMALE; FIBRIN CLOT; FIBRIN POLYMERIZATION; FIBRINOGEN BLOOD LEVEL; FIBRINOGEN KYOTO VI; GENE AMPLIFICATION; GENE MUTATION; HETEROZYGOTE; HUMAN; IMMUNOBLOTTING; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA TRANSLATION; SCANNING ELECTRON MICROSCOPY; STOP CODON;

AFIBRINOGENEMIA; AMINO ACIDS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; FIBRINOGEN; HUMANS; MICROSCOPY, ELECTRON, SCANNING; MIDDLE AGED;

EID: 84855186874     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32834cb243     Document Type: Article

References (11)

1. Doolittle RF, Bouma IH, Cottrell BA, Strong D, Watt KWK. The covalent structure of human fibrinogen. In: Bing DH, editor. The chemistry and physiology of the human plasma proteins. New York, New York: Pergamon Press; 1979. pp.77-95.
2. Doolittle RF. Fibrinogen and fibrin. Sci Amer 1981; 245:92-101.
3. Weisel JW. Fibrinogen and fibrin. Adv Protein Chem 2005; 70:247-299. (Pubitemid 40544785)
4. Fibrinogen variants. http://site.geht.org/site/Pratiques- Professionnelles/ Base-de-donnees-Fibrinogene/Base-de-donnees/Base-de-donnees- desvariants-du-Fibrinogene-40-.html [updated on 01/02/2011]
5. Sugo T, Nakamikawa C, Yoshida N, Niwa K, Sameshima M, Mimuro J, et al. End-linked homodimers in fibrinogen Osaka VI with a Bb-chain extension lead to fragile clot structure. Blood 2000; 96:3779-3785.
6. Kamijyo Y, Hirota-Kawadobora M, Yamauchi K, Terasawa F, Honda T, Ikeya M, et al. Analysis of plasmin generation and clot lysis of plasma fibrinogen purified from a heterozygous dysfibrinogenemia, BbGly15Cys (Hamamatsu II). Blood Coagul Fibrinolysis 2009; 20:726-732.
7. Terasawa F, Okumura N, Kitano K, Hayashida N, Shimosaka M, Okazaki M, et al. Hypofibrinogenemia associated with a heterozygous missense mutation g 153Cys to Arg (Matsumoto IV): In vitro expression demonstrates defective secretion of the variant fibrinogen. Blood 1999; 94:4122-4131.
8. Hirota-Kawadobora M, Terasawa F, Yonekawa O, Sahara N, Shimizu E, Okumura N, et al. Fibrinogens Kosai and Ogasa: Bb15Gly(Cys (GGT(TGT) substitution associated with impairment of fibrinopeptide B release and lateral aggregation. J Thromb Haemost 2003; 1:275-283.
9. Takebe M, Soe G, Kohno I, Sugo T, Matsuda M. Calcium ion-dependent monoclonal antibody against human fibrinogen: Preparation, characterization, and application to fibrinogen purification. Thromb Haemost 1995; 73:662-667.
10. Okumura N, Gorkun OV, Lord ST. Severely impaired polymerization of recombinant fibrinogen g-364 Asp->His, the substitution discovered in a heterozygous individual. J Biol Chem 1997; 272:29596-29601. (Pubitemid 27508049)
11. Holm B, Nilsen DWT, Kierulf P, Godal HC. Purification and characterization of 3 fibrinogens with different molecular weights obtained from normal human plasma. Thromb Res 1985; 37:165-176. (Pubitemid 15163084)